跳至主要内容
临床试验/ACTRN12612001254886
ACTRN12612001254886终止3 期

Among women with first trimester miscarriage, is the combination of mifepristone plus misoprostol superior to misoprostol alone for reducing the need for surgical uterine evacuation and repeat doses of misoprostol?

andini Somanathan0 个研究点目标入组 53 人开始时间: 2012年11月28日最近更新:

试验速览

阶段
3 期
状态
终止
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Patients will be included who have a positive serum beta hCG and are less than 13 weeks pregnant, as determined by the size of their gestational sac or crown rump length on ultrasound. Definitions for types of miscarriage are:
  • 1) Early embryonic demise = Mean sac diameter (MSD) >20mm with nil internal structures
  • 2) Anembryonic pregnancy = empty gestational sac of at least 12mm and no growth over 3 or more days
  • 3) Early fetal demise = fetus crown rump length (CRL) at least 6mm with nil fetal heart beat on transvaginal USS
  • 4) Incomplete miscarriage = mixed echogenicity within endometrial cavity +/- disordered gestational sac

排除标准

  • 1) severe haemorrhage or pain
  • 2) pyrexia
  • 3) allergy or contraindication to misoprostol or mifepristone
  • 4) current anticoagulation

研究者

发起方
andini Somanathan

相似试验